Effect of Duration and Intermittency of Rifampin on Tuberculosis Treatment Outcomes: A Systematic Review and Meta-Analysis
Dick Menzies(McGill University), William J. Burman(Case Western Reserve University), Christian Lienhardt(Institut de Recherche pour le Développement), Madhukar Pai(McGill University), Anita Paydar(McGill University), Andrea Benedetti(Montreal Heart Institute), Ian Martin(Montreal Heart Institute), Andrew Vernon(Centers for Disease Control and Prevention), Sarah Royce(University of California, San Francisco)
Cited by 225
Related Papers
Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis
|Clinical Infectious Diseases|2016|1.5k
Tuberculosis
|Nature Reviews Disease Primers|2016|1.2k
Updated guidelines for using Interferon Gamma Release Assays to detect Mycobacterium tuberculosis infection - United States, 2010.
|PubMed|2010|1.1k
Guidelines for Using the QuantiFERON-TB Gold Test for Detecting Mycobacterium tuberculosis Infection, United States
|PsycEXTRA Dataset|2005|694
Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis
|New England Journal of Medicine|2021|548